Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells.

Schmidt A, Oberle N, Weiss EM, Vobis D, Frischbutter S, Baumgrass R, Falk CS, Haag M, Brügger B, Lin H, Mayr GW, Reichardt P, Gunzer M, Suri-Payer E, Krammer PH.

Sci Signal. 2011 Dec 20;4(204):ra90. doi: 10.1126/scisignal.2002179.

PMID:
22375050
2.

Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells.

Weiss EM, Schmidt A, Vobis D, Garbi N, Lahl K, Mayer CT, Sparwasser T, Ludwig A, Suri-Payer E, Oberle N, Krammer PH.

J Immunol. 2011 Aug 15;187(4):1684-91. doi: 10.4049/jimmunol.1002321. Epub 2011 Jul 11.

3.

Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients.

Fritzsching B, Haas J, König F, Kunz P, Fritzsching E, Pöschl J, Krammer PH, Brück W, Suri-Payer E, Wildemann B.

PLoS One. 2011 Mar 18;6(3):e17988. doi: 10.1371/journal.pone.0017988.

4.

Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.

Klein S, Kretz CC, Ruland V, Stumpf C, Haust M, Hartschuh W, Hartmann M, Enk A, Suri-Payer E, Oberle N, Krammer PH, Kuhn A.

Ann Rheum Dis. 2011 Aug;70(8):1475-81. doi: 10.1136/ard.2009.116525. Epub 2010 Nov 19.

PMID:
21097800
5.

Regulatory T cells control macrophage accumulation and activation in lymphoma.

Galani IE, Wendel M, Stojanovic A, Jesiak M, Müller MM, Schellack C, Suri-Payer E, Cerwenka A.

Int J Cancer. 2010 Sep 1;127(5):1131-40. doi: 10.1002/ijc.25132.

6.

FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.

Heid JB, Schmidt A, Oberle N, Goerdt S, Krammer PH, Suri-Payer E, Klemke CD.

J Invest Dermatol. 2009 Dec;129(12):2875-85. doi: 10.1038/jid.2009.175. Epub 2009 Jul 23.

7.

Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke.

Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R.

Nat Med. 2009 Feb;15(2):192-9. doi: 10.1038/nm.1927. Epub 2009 Jan 25.

PMID:
19169263
8.

Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.

Korporal M, Haas J, Balint B, Fritzsching B, Schwarz A, Moeller S, Fritz B, Suri-Payer E, Wildemann B.

Arch Neurol. 2008 Nov;65(11):1434-9. doi: 10.1001/archneur.65.11.1434.

PMID:
19001161
9.

Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands.

Wendel M, Galani IE, Suri-Payer E, Cerwenka A.

Cancer Res. 2008 Oct 15;68(20):8437-45. doi: 10.1158/0008-5472.CAN-08-1440.

10.

The day-3 thymectomy model for induction of multiple organ-specific autoimmune diseases.

Suri-Payer E, Wei K, Tung K.

Curr Protoc Immunol. 2001 May;Chapter 15:Unit 15.16. doi: 10.1002/0471142735.im1516s32.

PMID:
18432733
11.

Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis.

Haas J, Schopp L, Storch-Hagenlocher B, Fritzsching B, Jacobi C, Milkova L, Fritz B, Schwarz A, Suri-Payer E, Hensel M, Wildemann B.

Blood. 2008 Jan 15;111(2):761-6. Epub 2007 Oct 29.

13.

Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.

Nummer D, Suri-Payer E, Schmitz-Winnenthal H, Bonertz A, Galindo L, Antolovich D, Koch M, Büchler M, Weitz J, Schirrmacher V, Beckhove P.

J Natl Cancer Inst. 2007 Aug 1;99(15):1188-99. Epub 2007 Jul 24.

PMID:
17652277
14.

Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis.

Haas J, Fritzsching B, Trübswetter P, Korporal M, Milkova L, Fritz B, Vobis D, Krammer PH, Suri-Payer E, Wildemann B.

J Immunol. 2007 Jul 15;179(2):1322-30.

15.

Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.

Franz B, Fritzsching B, Riehl A, Oberle N, Klemke CD, Sykora J, Quick S, Stumpf C, Hartmann M, Enk A, Ruzicka T, Krammer PH, Suri-Payer E, Kuhn A.

Arthritis Rheum. 2007 Jun;56(6):1910-20.

16.

Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals.

Fritzsching B, Korporal M, Haas J, Krammer PH, Suri-Payer E, Wildemann B.

J Neurol Sci. 2006 Dec 21;251(1-2):91-7. Epub 2006 Nov 7.

PMID:
17092518
17.

FOXP3+ regulatory T cells: Current controversies and future perspectives.

Banham AH, Powrie FM, Suri-Payer E.

Eur J Immunol. 2006 Nov;36(11):2832-6. Review.

18.

Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death.

Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, Poschl J, Krammer P, Linderkamp O, Suri-Payer E.

Blood. 2006 Nov 15;108(10):3371-8. Epub 2006 Jul 25.

19.

Regulatory T cells in experimental autoimmune disease.

Suri-Payer E, Fritzsching B.

Springer Semin Immunopathol. 2006 Aug;28(1):3-16. Epub 2006 Jul 13. Review.

PMID:
16838180
20.

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.

Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, Poenitz N, Sykora J, Banham AH, Roncador G, Kuhn A, Goerdt S, Krammer PH, Suri-Payer E.

Leukemia. 2006 Jun;20(6):1123-9.

PMID:
16557241
21.

Death receptor signaling and its function in the immune system.

Fas SC, Fritzsching B, Suri-Payer E, Krammer PH.

Curr Dir Autoimmun. 2006;9:1-17. Review.

PMID:
16394652
22.

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

Haas J, Hug A, Viehöver A, Fritzsching B, Falk CS, Filser A, Vetter T, Milkova L, Korporal M, Fritz B, Storch-Hagenlocher B, Krammer PH, Suri-Payer E, Wildemann B.

Eur J Immunol. 2005 Nov;35(11):3343-52.

23.

CD4+CD25+-regulatory T cells from mouse to man.

Wing K, Suri-Payer E, Rudin A.

Scand J Immunol. 2005 Jul;62(1):1-15. Review.

24.

CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses.

Wing K, Larsson P, Sandström K, Lundin SB, Suri-Payer E, Rudin A.

Immunology. 2005 Aug;115(4):516-25.

25.

In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death.

Fritzsching B, Oberle N, Eberhardt N, Quick S, Haas J, Wildemann B, Krammer PH, Suri-Payer E.

J Immunol. 2005 Jul 1;175(1):32-6.

26.

Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients.

Lundgren A, Strömberg E, Sjöling A, Lindholm C, Enarsson K, Edebo A, Johnsson E, Suri-Payer E, Larsson P, Rudin A, Svennerholm AM, Lundin BS.

Infect Immun. 2005 Jan;73(1):523-31.

27.

Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.

Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A.

Clin Exp Allergy. 2004 Sep;34(9):1364-72.

PMID:
15347368
28.
29.

Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice.

Raghavan S, Fredriksson M, Svennerholm AM, Holmgren J, Suri-Payer E.

Clin Exp Immunol. 2003 Jun;132(3):393-400.

30.

Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals.

Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS.

Infect Immun. 2003 Apr;71(4):1755-62.

31.

CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells.

Wing K, Lindgren S, Kollberg G, Lundgren A, Harris RA, Rudin A, Lundin S, Suri-Payer E.

Eur J Immunol. 2003 Mar;33(3):579-87.

32.

Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood.

Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E.

Immunology. 2002 Jun;106(2):190-9.

33.
34.

Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells.

Suri-Payer E, Amar AZ, McHugh R, Natarajan K, Margulies DH, Shevach EM.

Eur J Immunol. 1999 Feb;29(2):669-77.

35.

Regulation of anti-DNA B cells in recombination-activating gene-deficient mice.

Xu H, Li H, Suri-Payer E, Hardy RR, Weigert M.

J Exp Med. 1998 Oct 5;188(7):1247-54.

36.

T lymphocyte-mediated control of autoimmunity.

Shevach EM, Thornton A, Suri-Payer E.

Novartis Found Symp. 1998;215:200-11; discussion 211-30.

PMID:
9760581
37.
38.

Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells.

Suri-Payer E, Kehn PJ, Cheever AW, Shevach EM.

J Immunol. 1996 Aug 15;157(4):1799-805.

PMID:
8759770

Supplemental Content

Loading ...
Support Center